SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-115699
Filing Date
2022-11-08
Accepted
2022-11-08 08:01:15
Documents
14
Period of Report
2022-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2229948d1_8k.htm   iXBRL 8-K 25942
2 EXHIBIT 99.1 tm2229948d1_ex99-1.htm EX-99.1 57094
6 GRAPHIC tm2229948d1_ex99-1img001.jpg GRAPHIC 4047
  Complete submission text file 0001104659-22-115699.txt   273523

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA lqda-20221108.xsd EX-101.SCH 3033
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE lqda-20221108_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lqda-20221108_pre.xml EX-101.PRE 22595
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2229948d1_8k_htm.xml XML 3683
Mailing Address 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560
Business Address 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560 919.328.4400
Liquidia Corp (Filer) CIK: 0001819576 (see all company filings)

IRS No.: 851710962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39724 | Film No.: 221367317
SIC: 2834 Pharmaceutical Preparations